You are viewing the site in preview mode

Skip to main content
Fig. 3 | BMC Public Health

Fig. 3

From: Effect of Covid-19 pandemic on azithromycin, chloroquine/hydroxychloroquine and ivermectin outpatient consumption in Brazil: a joinpoint regression analysis

Fig. 3

Ivermectin and new COVID-19 cases in Brazil and its geographical regions. Brazil, 2020 to 2021. Flag 1: Technical report of the FBM-Br advocating using chloroquine and hydroxychloroquine in patients diagnosed with COVID-19. Flag 2: The Minister of Health launched the ‘TrateCov’ app in person in Manaus, and the COVID-19 vaccination has begun. Flag 3: Over 60% of COVID-19 vaccination coverage for the first dose

Back to article page

BMC Public Health

ISSN: 1471-2458

Contact us